Role of GFAP in CNS injuries

Neuroscience Letters

Volumn 565, Issue , 2014, Pages 7-13

  Brenner, Michael ^a,b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Astrocyte; CNS injury; GFAP; Ischemia; Neurotrauma; Reactive gliosis

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; VIMENTIN;

ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN INJURY; DEPRESSION; GENE OVEREXPRESSION; GROWTH RATE; HUMAN; ISCHEMIA; LABORATORY; LONG TERM POTENTIATION; MYELINATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCAR FORMATION;

ASTROCYTE; CNS INJURY; GFAP; ISCHEMIA; NEUROTRAUMA; REACTIVE GLIOSIS;

ANIMALS; ASTROCYTES; BLOOD-BRAIN BARRIER; BRAIN INJURIES; BRAIN ISCHEMIA; CELL ADHESION; CELL PROLIFERATION; LONG-TERM POTENTIATION; LONG-TERM SYNAPTIC DEPRESSION; MICE, KNOCKOUT; MYELIN SHEATH; NERVE TISSUE PROTEINS; NEURONS; VIMENTIN;

EID: 84897071153     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.01.055     Document Type: Review

References (48)

1. Eng L.F., Ghirnikar R.S. GFAP and astrogliosis. Brain Pathol. 1994, 4:229-237.
2. Pekny M., Wilhelmsson U., Pekna M. The dual role of astrocyte activation and reactive gliosis. Neurosci. Lett. 2014, 565:30-38.
3. Messing A., Head M.W., Galles K., Galbreath E.J., Goldman J.E., Brenner M. Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice. Am. J. Pathol. 1998, 152:391-398.
4. Brenner M., Goldman J.E., Quinlan R.A., Messing A. Astrocytes in (patho)physiology of the nervous system. Alexander Disease: A Genetic Disorder of Astrocytes 2009, 591-648. Springer, New York, NY, (Chapter 24). V. Parpura, P. Haydon (Eds.).
5. Weinstein D.E., Shelanski M.L., Liem R.K. Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons. J. Cell Biol. 1991, 112:1205-1213.
6. Gomi H., Yokoyama T., Fujimoto K., Ikeda T., Katoh A., Itoh T., Itohara S. Mice devoid of the glial fibrillary acidic protein develop normally and are susceptible to scrapie prions. Neuron 1995, 14:29-41.
7. Pekny M., Leveen P., Pekna M., Eliasson C., Berthold C.H., Westermark B., Betsholtz C. Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally. EMBO J. 1995, 14:1590-1598.
8. McCall M.A., Gregg R.G., Behringer R.R., Brenner M., Delaney C.L., Galbreath E.J., Zhang C.L., Pearce R.A., Chiu S.Y., Messing A. Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:6361-6366.
9. Liedtke W., Edelmann W., Bieri P.L., Chiu F.C., Cowan N.J., Kucherlapati R., Raine C.S. GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron 1996, 17:607-615.
10. Gimenez Y.R.M., Langa F., Menet V., Privat A. Comparative anatomy of the cerebellar cortex in mice lacking vimentin, GFAP, and both vimentin and GFAP. Glia 2000, 31:69-83.
11. Pekny M., Johansson C.B., Eliasson C., Stakeberg J., Wallen A., Perlmann T., Lendahl U., Betsholtz C., Berthold C.H., Frisen J. Abnormal reaction to central nervous system injury in mice lacking glial fibrillary acidic protein and vimentin. J. Cell Biol. 1999, 145:503-514.
12. Pekny M., Eliasson C., Chien C.L., Kindblom L.G., Liem R., Hamberger A., Betsholtz C. GFAP-deficient astrocytes are capable of stellation in vitro when cocultured with neurons and exhibit a reduced amount of intermediate filaments and an increased cell saturation density. Exp. Cell Res. 1998, 239:332-343.
13. Lepekhin E.A., Eliasson C., Berthold C.H., Berezin V., Bock E., Pekny M. Intermediate filaments regulate astrocyte motility. J. Neurochem. 2001, 79:617-625.
14. Shibuki K., Gomi H., Chen L., Bao S., Kim J.J., Wakatsuki H., Fujisaki T., Fujimoto K., Katoh A., Ikeda T., Chen C., Thompson R.F., Itohara S. Deficient cerebellar long-term depression, impaired eyeblink conditioning, and normal motor coordination in GFAP mutant mice. Neuron 1996, 16:587-599.
15. Wilhelmsson U., Li L., Pekna M., Berthold C.H., Blom S., Eliasson C., Renner O., Bushong E., Ellisman M., Morgan T.E., Pekny M. Absence of glial fibrillary acidic protein and vimentin prevents hypertrophy of astrocytic processes and improves post-traumatic regeneration. J. Neurosci. 2004, 24:5016-5021.
16. Xu K., Malouf A.T., Messing A., Silver J. Glial fibrillary acidic protein is necessary for mature astrocytes to react to beta-amyloid. Glia 1999, 25:390-403.
17. Menet V., Gimenez Y.R.M., Sandillon F., Privat A. GFAP null astrocytes are a favorable substrate for neuronal survival and neurite growth. Glia 2000, 31:267-272.
18. Menet V., Gimenez y Ribotta M., Chauvet N., Drian M.J., Lannoy J., Colucci-Guyon E., Privat A. Inactivation of the glial fibrillary acidic protein gene, but not that of vimentin, improves neuronal survival and neurite growth by modifying adhesion molecule expression. J. Neurosci. 2001, 21:6147-6158.
19. Wilhelmsson U., Faiz M., de Pablo Y., Sjoqvist M., Andersson D., Widestrand A., Potokar M., Stenovec M., Smith P.L., Shinjyo N., Pekny T., Zorec R., Stahlberg A., Pekna M., Sahlgren C., Pekny M. Astrocytes negatively regulate neurogenesis through the Jagged1-mediated Notch pathway. Stem Cells 2012, 30:2320-2329.
20. Toda M., Asou H., Miura M., Toya S., Uyemura K. GFAP transfected cells produce laminin, leading to neurite outgrowth promotion. Neuroreport 1994, 5:1969-1972.
21. Menet V., Prieto M., Privat A., Gimenez y Ribotta M. Axonal plasticity and functional recovery after spinal cord injury in mice deficient in both glial fibrillary acidic protein and vimentin genes. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:8999-9004.
22. Kinouchi R., Takeda M., Yang L., Wilhelmsson U., Lundkvist A., Pekny M., Chen D.F. Robust neural integration from retinal transplants in mice deficient in GFAP and vimentin. Nat. Neurosci. 2003, 6:863-868.
23. Eliasson C., Sahlgren C., Berthold C.H., Stakeberg J., Celis J.E., Betsholtz C., Eriksson J.E., Pekny M. Intermediate filament protein partnership in astrocytes. J. Biol. Chem. 1999, 274:23996-24006.
24. Wang X., Messing A., David S. Axonal and nonneuronal cell responses to spinal cord injury in mice lacking glial fibrillary acidic protein. Exp. Neurol. 1997, 148:568-576.
25. Schonewille M., Gao Z., Boele H.J., Veloz M.F., Amerika W.E., Simek A.A., De Jeu M.T., Steinberg J.P., Takamiya K., Hoebeek F.E., Linden D.J., Huganir R.L., De Zeeuw C.I. Reevaluating the role of LTD in cerebellar motor learning. Neuron 2011, 70:43-50.
26. Hughes E.G., Maguire J.L., McMinn M.T., Scholz R.E., Sutherland M.L. Loss of glial fibrillary acidic protein results in decreased glutamate transport and inhibition of PKA-induced EAAT2 cell surface trafficking. Brain Res. Mol. Brain Res. 2004, 124:114-123.
27. Sullivan S.M., Lee A., Björkman S.T., Meller S.M., Sullivan R.K., Poronnik P., Colditz P.B., Pow D.V. Cytoskeletal anchoring of GLAST determines susceptibility to brain damage. An identified role for GFAP. J. Biol. Chem. 2007, 282:2914-2923.
28. Li L., Lundkvist A., Andersson D., Wilhelmsson U., Nagai N., Pardo A.C., Nodin C., Stahlberg A., Aprico K., Larsson K., Yabe T., Moons L., Fotheringham A., Davies I., Carmeliet P., Schwartz J.P., Pekna M., Kubista M., Blomstrand F., Maragakis N., Nilsson M., Pekny M. Protective role of reactive astrocytes in brain ischemia. J. Cereb. Blood Flow Metab. 2008, 28:468-481.
29. Maragakis N.J., Rothstein J.D. Glutamate transporters: animal models to neurologic disease. Neurobiol. Dis. 2004, 15:461-473.
30. Pekny M., Eliasson C., Siushansian R., Ding M., Dixon S.J., Pekna M., Wilson J.X., Hamberger A. The impact of genetic removal of GFAP and/or vimentin on glutamine levels and transport of glucose and ascorbate in astrocytes. Neurochem. Res. 1999, 24:1357-1362.
31. Tatzelt J., Maeda N., Pekny M., Yang S.L., Betsholtz C., Eliasson C., Cayetano J., Camerino A.P., DeArmond S.J., Prusiner S.B. Scrapie in mice deficient in apolipoprotein E or glial fibrillary acidic protein. Neurology 1996, 47:449-453.
32. Liedtke W., Edelmann W., Chiu F.C., Kucherlapati R., Raine C.S. Experimental autoimmune encephalomyelitis in mice lacking glial fibrillary acidic protein is characterized by a more severe clinical course and an infiltrative central nervous system lesion. Am. J. Pathol. 1998, 152:251-259.
33. Stenzel W., Soltek S., Schluter D., Deckert M. The intermediate filament GFAP is important for the control of experimental murine Staphylococcus aureus-induced brain abscess and Toxoplasma encephalitis. J. Neuropathol. Exp. Neurol. 2004, 63:631-640.
34. Hanbury R., Ling Z.D., Wuu J., Kordower J.H. GFAP knockout mice have increased levels of GDNF that protect striatal neurons from metabolic and excitotoxic insults. J. Comp. Neurol. 2003, 461:307-316.
35. Nawashiro H., Messing A., Azzam N., Brenner M. Mice lacking GFAP are hypersensitive to traumatic cerebrospinal injury. Neuroreport 1998, 9:1691-1696.
36. Lundkvist A., Reichenbach A., Betsholtz C., Carmeliet P., Wolburg H., Pekny M. Under stress, the absence of intermediate filaments from Muller cells in the retina has structural and functional consequences. J. Cell Sci. 2004, 117:3481-3488.
37. Verardo M.R., Lewis G.P., Takeda M., Linberg K.A., Byun J., Luna G., Wilhelmsson U., Pekny M., Chen D.F., Fisher S.K. Abnormal reactivity of muller cells after retinal detachment in mice deficient in GFAP and vimentin. Invest. Ophthalmol. Vis. Sci. 2008, 49:3659-3665.
38. Chen Z.L., Yao Y., Norris E.H., Kruyer A., Jno-Charles O., Akhmerov A., Strickland S. Ablation of astrocytic laminin impairs vascular smooth muscle cell function and leads to hemorrhagic stroke. J. Cell Biol. 2013, 202:381-395.
39. Nawashiro H., Brenner M., Fukui S., Shima K., Hallenbeck J.M. High susceptibility to cerebral ischemia in GFAP-null mice. J. Cereb. Blood Flow Metab. 2000, 20:1040-1044.
40. Nawashiro H., Huang S., Brenner M., Shima K., Hallenbeck J.M. ICP monitoring following bilateral carotid occlusion in GFAP-null mice. Acta Neurochir. Suppl. 2002, 81:269-270.
41. Garcia J.H., Liu K.F., Yoshida Y., Chen S., Lian J. Brain microvessels: factors altering their patency after the occlusion of a middle cerebral artery (Wistar rat). Am. J. Pathol. 1994, 145:728-740.
42. Pantoni L., Garcia J.H., Gutierrez J.A. Cerebral white matter is highly vulnerable to ischemia. Stroke 1996, 27:1641-1646.
43. Ding M., Eliasson C., Betsholtz C., Hamberger A., Pekny M. Altered taurine release following hypotonic stress in astrocytes from mice deficient for GFAP and vimentin. Brain Res. Mol. Brain Res. 1998, 62:77-81.
44. Anderova M., Kubinova S., Mazel T., Chvatal A., Eliasson C., Pekny M., Sykova E. Effect of elevated K(+), hypotonic stress, and cortical spreading depression on astrocyte swelling in GFAP-deficient mice. Glia 2001, 35:189-203.
45. Carmignoto G., Gomez-Gonzalo M. The contribution of astrocyte signalling to neurovascular coupling. Brain Res. Rev. 2010, 63:138-148.
46. Pekny M., Stanness K.A., Eliasson C., Betsholtz C., Janigro D. Impaired induction of blood-brain barrier properties in aortic endothelial cells by astrocytes from GFAP-deficient mice. Glia 1998, 22:390-400.
47. Emsley J.G., Macklis J.D. Astroglial heterogeneity closely reflects the neuronal-defined anatomy of the adult murine CNS. Neuron Glia Biol. 2006, 2:175-186.
48. Yeo S., Bandyopadhyay S., Messing A., Brenner M. Transgenic analysis of GFAP promoter elements. Glia 2013, 61:1488-1499.